Met Life Investment Management, LLC Pa Vmed Inc. Transaction History

Met Life Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.46 - $8.74 $43,901 - $155,974	-17,846 Closed	0 $0
Q3 2021 May 17, 2024	SELL	$5.1 - $9.39 $55,105 - $101,458	-10,805 Reduced 37.71%	17,846 $152,000
Q3 2021 Jun 21, 2023	BUY	$5.1 - $9.39 $91,014 - $167,573	17,846 New	17,846 $152,000
Q3 2021 Mar 22, 2023	SELL	$5.1 - $9.39 $55,105 - $101,458	-10,805 Reduced 37.71%	17,846 $152,000
Q3 2021 Nov 15, 2021	SELL	$5.1 - $9.39 $55,105 - $101,458	-10,805 Reduced 37.71%	17,846 $152,000
Q2 2021 May 17, 2024	BUY	$3.95 - $6.88 $113,171 - $197,118	28,651 New	28,651 $183,000
Q2 2021 Jun 21, 2023	BUY	$3.95 - $6.88 $113,171 - $197,118	28,651 New	28,651 $183,000
Q2 2021 Mar 22, 2023	BUY	$3.95 - $6.88 $113,171 - $197,118	28,651 New	28,651 $183,000
Q2 2021 Aug 16, 2021	BUY	$3.95 - $6.88 $113,171 - $197,118	28,651 New	28,651 $183,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $52.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.